The Chicago White Sox were hit with some devastating news back in January. The news that closer Liam Hendriks had been diagnosed with non-Hodgkin’s lymphoma. He proceeded to start treatment immediately.
At that time, the club didn’t provide many specifics about the expected absence or when he might be back. At the end of spring training, they chose not to put him on the 60-Day IL. In the hopes, that he would be able to return within two months. The righty himself then announced a couple of weeks ago that he had completed his chemotherapy treatment, which was clearly successful based on today’s update.
“REMISSION,” Hendriks posted to Instagram along with pictures and video of him from throughout his cancer fight. “It’s official. I’m cancer free.”
It’s a tremendous bit of good news for Hendriks, his family, teammates, fans of the Sox and baseball fans all around. Hendriks has made connections all over throughout his lengthy career which has included stops with the Toronto Blue Jays, Oakland Athletics, Minnesota Twins and Kansas City Royals before he inked the deal in Chicago.
While in Oakland, he established himself as one of the league’s premier closers. Since the start of the 2019 season, the now 34-year-old has racked up 114 saves. Trailing only Kenley Jansen and Josh Hader in that span.
It is still unclear as to when Hendriks will be able to return to the pitchers mound but more information will surely come in the next few days and weeks. For now, its safe to say that the most important part is part is behind him and Fantom Sports joins the rest of the baseball world in congratulating Liam Hendriks on his recovery.
Get the latest sports news via Fantom Sports Industries. Follow us on Twitter via @Fantom_sports. Like us on Facebook Fantom Sports Industries. Subscribe to our YouTube channel via Fantom Sports. Subscribe to our Newsletter! Shop Fantom Sports Industries Merch.
Invest in your favorite athletes like stocks with “Prediction Strike!” and Use code FANTOM when you sign up.
Pingback:Cade Marlowe may be an Answer to Mariners' Early Season Issues